Bayer to Present Data from Cardiovascular Portfolio, Including Finerenone

(PLX AI) - Bayer to present data from cardiovascular portfolio, including late breaking data from Phase III FIGARO-DKD (finerenone) and various Xarelto studies at the ESC Congress 2021.• A total of three

Related Keywords

,Bayer ,Present ,Data ,Rom ,Ardiovascular ,Portfolio ,Ncluding ,Finerenone ,பேயர் ,அட்டா ,ரோம் ,